Our Speakers



Our Speakers

Eugene	Zhukovsky
Eugene Zhukovsky

CSO

Biomunex Pharmaceuticals

Jeanette	Leusen
Jeanette Leusen

Group Leader, Tumor Immunology

UMC Utrecht

Lindy Durrant
Lindy Durrant

Professor, CSO

Nottingham University, Scancell Ltd

Sophia Karagiannis
Sophia Karagiannis

Head of Cancer Antibody Discovery and Immunotherapy

King's College London

Thomas Valerius
Thomas Valerius

Professor-Department of stem cell and immunotherapy

Kiel Life Science, Germany

Stefan Glueck
Stefan Glueck

Vice President, Global Medical Affairs Solid Tumors, Immuno-Oncology and Early Assets, Clegene

Celgene

Kandeepan Ganeshaligam
Kandeepan Ganeshaligam

Executive Director, Oncology Therapeutic Area Head

Merck Sharp & Dohme Ltd, UK

Robert Hawkins
Robert Hawkins

Professor & Medical Oncologist, University of Manchester

Michelle Morrow
Michelle Morrow

Vice President, Preclinical and Translational Pharmacology

F-Star Biotechnology Ltd, UK

David Giljohann
David Giljohann

CEO

Exicure, USA

Alex Blyth
Alex Blyth

CEO

LIfT BioSciences, UK

Heinz Lubenau
Heinz Lubenau

Chief Operating Officer, Co-Founder

Vaximm, Germany

Zoe Johnson
Zoe Johnson

Head Translational Research & Early Development

iOnctura, Switzerland

Stephen Beers
Stephen Beers

Professor of Immunology and Immunotherapy

University of Southampton, UK

Angus Dalgleish
Angus Dalgleish

Professor of Oncology

St. George's University of London, UK

Ann White
Ann White

Senior Principal Scientist, UCB Celltech

Lucia Pattarini
Lucia Pattarini

Project Manager, Immuno- Oncology

Servier, France

John Maudsley
John Maudsley

Chief Executive Officer

Cancer Vaccines Ltd

Liselotte Brix
Liselotte Brix

Co founderChief Scientific Officer

Immudex, USA

Robert Boyd
Robert Boyd

UK Site Head and Scientific Director,Oxford BioTherapeutics

Will Arends
Will Arends

Chartered (UK) and European Patent Attorney

Marks & Clerk, UK

Mark Creighton-Gutteridge
Mark Creighton-Gutteridge

Director, Head of Discovery and New Technologies, Oncology Cell Therapy R&D

GSK, UK

Anneli Anderson
Anneli Anderson

Scientific Project Manager, Nebion, Switzerland

Andrew Sewell
Andrew Sewell

Professor, Division of Infection and Immunity

Cardiff University, UK

Lolke de Haan
Lolke de Haan

Senior Director R&D, Toxicology, Global Immuno-Oncology Nonclinical Safety Lead

ad MedImmune, UK

Louise Affleck
Louise Affleck

UK Team Leader

Cisbio, UK

Emiliano Melandri
Emiliano Melandri

Global Product Manager Immunology

Miltenyi Biotech, UK

Sebastien Tabruyn
Sebastien Tabruyn

Chief Scientific Officer

TransCure Bioservices, France

Renier Heijkants
Renier Heijkants

Scientist

APO-T, Netherlands

Angela Vasaturo
Angela Vasaturo

Senior Field Application Scientist

Ultivue

Esther Breij
Esther Breij

Senior Director, Translational Research

Genmab

Carolyn Edwards
Carolyn Edwards

Senior Scientist, Project Manager

Crescendo Biologics

Dimitris Lagos
Dimitris Lagos

Senior Lecturer, Immunology

University of York, UK

Deborah Wright
Deborah Wright

Scientist II

AgenTus, UK

Christian Gojak
Christian Gojak

Head of Marketing & Digital Sales

PromoCell, Germany

Thomas Mørch Frøsig
Thomas Mørch Frøsig

Chief Executive Officer

ImmuMap, Denmark

Juliette Lamy
Juliette Lamy

Senior Scientist

ImmunXperts, Belgium

Mike Dyson
Mike Dyson

Chief Technology Officer

Iontas, UK

Katja Klausz
Katja Klausz

senior scientist and project leader

University Hospital Schleswig-Holstein, Germany

Christoph Wuelfing
Christoph Wuelfing

Professor, Immunology

University of Bristol, UK

Robin Campbell
Robin Campbell

Director

Immunitrack, Denmark

John Bridgeman
John Bridgeman

Director

Cell Therapy Research Immetacyte, UK

Kathrin Thell
Kathrin Thell

Scientist

Apeiron Biologics, Austria


Loading...